ACADIAN ASSET MANAGEMENT LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 107 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$177
-93.8%
98,946
-88.3%
0.00%
-92.9%
Q4 2022$2,873
-99.9%
845,744
-0.6%
0.01%
-44.0%
Q3 2022$4,643,000
+455.4%
850,576
+359.0%
0.02%
+525.0%
Q2 2022$836,000
-77.2%
185,296
-62.9%
0.00%
-73.3%
Q1 2022$3,674,000
+1003.3%
498,922
+776.2%
0.02%
+1400.0%
Q1 2019$333,000
+540.4%
56,943
+1293.6%
0.00%
Q1 2017$52,0004,0860.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders